Forget buy-to-let! These FTSE 250 property stocks yield more than 5%

Roland Head looks at two FTSE 250 (INDEXFTSE:MCX) REITs with very different business models.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

If you’re looking for a property investment but are worried about a market crash, healthcare could be the answer.

According to the Investment Property Databank (IPD) Healthcare Index, primary healthcare properties — such as GP surgeries — have delivered a total return of more than 7% per year since 2007, with less risk than any other class of property.

The first stock I want to look at today is healthcare property REIT Assura (LSE: AGR), which develops and invests in GP surgeries. Assura earns 84% of its rent roll from the NHS.

Assura now owns 556 properties, out of a total UK market of around 9,000 GP surgeries and medical centres. The company says that this makes it the sector leader “in a highly fragmented market”.

One attraction of this business is that rent payments are likely to be supremely reliable. This compares favourably to retail property, for example, where many tenants are suffering financial problems.

What could go wrong?

One possible downside is that high demand for secure income means that healthcare rental yields are quite low.

In a trading statement issued today, the company said it had paid £108.2m for 39 medical centres and two developments during the first quarter. Collectively, these properties generate £5.5m of rent each year and have a weighted average lease term remaining of 13.3 years.

This suggests a gross rental yield of 5.1%, which seems fairly low to me, given that the group’s debt carries an average cost of 3.3%.

As a contrast, my second stock today has similar levels of gearing and an average debt cost of 2.9%. But it recently announced a £57m property acquisition with a net initial yield of 9.15%.

To sum up, my view on Assura is that investors are paying a high price for a secure income. Given that interest rates seem likely to rise, I think these shares are already fully priced.

One property stock I’d buy

The other company I mentioned above is FTSE 250 property firm Hansteen Holdings (LSE:HSTN). This group owns offices and industrial property, such as warehouses and distribution centres.

Demand for logistics properties is pretty high at the moment, due to the growth of internet shopping. Hansteen took advantage of this strength to sell its Dutch and German portfolios for €1.3bn in 2017. Earlier this year the firm continued to lock in gains on its portfolio, selling £116m of UK property.

Adding value

The proceeds from these sales have been used to fund significant returns to shareholders. Management said it has opted to return capital rather than buy new assets because high prices mean that opportunities for new investments are “limited”.

I like this conservative approach from management. I also like the company’s ability to buy properties and improve them by increasing occupancy and rental levels. This allows Hansteen to create value for shareholders in a way that I suspect may be harder for Assura.

Higher returns

Here’s another way of comparing the two companies. Hansteen generated a return on capital employed of 10.4% last year. Assura generated ROCE of just 4.1%.

Hansteen shares currently trade in line with their book value and offer a forward yield of 5.2%. I’d be happy to buy this stock today, despite the group’s exposure to the UK economy.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Roland Head has no position in any of the shares mentioned. The Motley Fool UK has recommended Hansteen Holdings. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »